東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/01/12 | 2,550 | 2,567 | 2,470 | 2,484 | -46 | -1.8% | 125,100 |
2024/01/11 | 2,523 | 2,535 | 2,501 | 2,530 | +13 | +0.5% | 105,400 |
2024/01/10 | 2,510 | 2,529 | 2,505 | 2,517 | +15 | +0.6% | 112,500 |
2024/01/09 | 2,434 | 2,509 | 2,431 | 2,502 | +92 | +3.8% | 180,200 |
2024/01/05 | 2,440 | 2,449 | 2,386 | 2,410 | -24 | -1% | 161,200 |
2024/01/04 | 2,366 | 2,434 | 2,326 | 2,434 | +82 | +3.5% | 130,800 |
2023/12/29 | 2,358 | 2,362 | 2,332 | 2,352 | -7 | -0.3% | 85,000 |
2023/12/28 | 2,360 | 2,362 | 2,343 | 2,359 | +2 | +0.1% | 74,200 |
2023/12/27 | 2,329 | 2,363 | 2,320 | 2,357 | +22 | +0.9% | 85,700 |
2023/12/26 | 2,368 | 2,369 | 2,330 | 2,335 | -22 | -0.9% | 83,100 |
2023/12/25 | 2,355 | 2,374 | 2,349 | 2,357 | +11 | +0.5% | 62,800 |
2023/12/22 | 2,326 | 2,350 | 2,312 | 2,346 | +26 | +1.1% | 100,600 |
2023/12/21 | 2,326 | 2,353 | 2,310 | 2,320 | -10 | -0.4% | 159,700 |
2023/12/20 | 2,315 | 2,350 | 2,315 | 2,330 | +30 | +1.3% | 96,400 |
2023/12/19 | 2,263 | 2,301 | 2,246 | 2,300 | +14 | +0.6% | 170,100 |
2023/12/18 | 2,227 | 2,295 | 2,223 | 2,286 | -3 | -0.1% | 138,400 |
2023/12/15 | 2,336 | 2,336 | 2,281 | 2,289 | -49 | -2.1% | 164,300 |
2023/12/14 | 2,335 | 2,351 | 2,308 | 2,338 | ±0 | ±0% | 110,300 |
2023/12/13 | 2,345 | 2,358 | 2,337 | 2,338 | -3 | -0.1% | 106,400 |
2023/12/12 | 2,370 | 2,379 | 2,340 | 2,341 | -32 | -1.3% | 103,100 |
2023/12/11 | 2,345 | 2,376 | 2,339 | 2,373 | +34 | +1.5% | 89,300 |
2023/12/08 | 2,370 | 2,381 | 2,329 | 2,339 | -52 | -2.2% | 110,300 |
2023/12/07 | 2,430 | 2,430 | 2,391 | 2,391 | -43 | -1.8% | 86,500 |
2023/12/06 | 2,406 | 2,439 | 2,403 | 2,434 | +28 | +1.2% | 79,600 |
2023/12/05 | 2,423 | 2,447 | 2,406 | 2,406 | -17 | -0.7% | 117,200 |
2023/12/04 | 2,435 | 2,440 | 2,403 | 2,423 | -41 | -1.7% | 97,500 |
2023/12/01 | 2,480 | 2,487 | 2,456 | 2,464 | -6 | -0.2% | 84,600 |
2023/11/30 | 2,454 | 2,471 | 2,434 | 2,470 | +19 | +0.8% | 91,800 |
2023/11/29 | 2,469 | 2,471 | 2,447 | 2,451 | -30 | -1.2% | 102,200 |
2023/11/28 | 2,445 | 2,484 | 2,430 | 2,481 | +31 | +1.3% | 107,600 |
2023/11/27 | 2,502 | 2,502 | 2,450 | 2,450 | -23 | -0.9% | 70,700 |
2023/11/24 | 2,505 | 2,505 | 2,458 | 2,473 | -18 | -0.7% | 116,400 |
2023/11/22 | 2,422 | 2,495 | 2,410 | 2,491 | +55 | +2.3% | 160,700 |
2023/11/21 | 2,444 | 2,444 | 2,393 | 2,436 | -8 | -0.3% | 180,300 |
2023/11/20 | 2,488 | 2,491 | 2,430 | 2,444 | -44 | -1.8% | 172,400 |
2023/11/17 | 2,460 | 2,488 | 2,443 | 2,488 | +14 | +0.6% | 174,100 |
2023/11/16 | 2,498 | 2,542 | 2,469 | 2,474 | -39 | -1.6% | 207,100 |
2023/11/15 | 2,508 | 2,530 | 2,483 | 2,513 | +5 | +0.2% | 235,800 |
2023/11/14 | 2,533 | 2,573 | 2,460 | 2,508 | -175 | -6.5% | 459,100 |
2023/11/13 | 2,673 | 2,703 | 2,664 | 2,683 | +31 | +1.2% | 150,300 |
2023/11/10 | 2,656 | 2,686 | 2,623 | 2,652 | -14 | -0.5% | 171,700 |
2023/11/09 | 2,706 | 2,727 | 2,650 | 2,666 | -53 | -1.9% | 230,400 |
2023/11/08 | 2,643 | 2,726 | 2,630 | 2,719 | +104 | +4% | 259,000 |
2023/11/07 | 2,618 | 2,660 | 2,592 | 2,615 | -103 | -3.8% | 424,400 |
2023/11/06 | 2,715 | 2,736 | 2,691 | 2,718 | -18 | -0.7% | 189,200 |
2023/11/02 | 2,782 | 2,790 | 2,729 | 2,736 | -46 | -1.7% | 112,700 |
2023/11/01 | 2,785 | 2,797 | 2,741 | 2,782 | +15 | +0.5% | 102,700 |
2023/10/31 | 2,683 | 2,777 | 2,683 | 2,767 | +93 | +3.5% | 199,900 |
2023/10/30 | 2,771 | 2,771 | 2,628 | 2,674 | -103 | -3.7% | 231,500 |
2023/10/27 | 2,709 | 2,779 | 2,680 | 2,777 | +75 | +2.8% | 178,600 |
301~
350
件表示中 / 6926件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 253,000円 | +15.0% | -7.3% | 2.77% | 8.30倍 | 0.78倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 444,100円 | +22.8% | +113.0% | 4.28% | 12.34倍 | 1.10倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 371,500円 | +14.5% | -2.3% | 2.42% | 13.59倍 | 0.72倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
鳥居薬 | 435,500円 | +7.1% | -35.0% | 2.76% | 36.01倍 | 1.01倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ゼリア新薬 | 222,900円 | +14.2% | +41.0% | 2.06% | 10.92倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム